Open communication with your doctors will catch any unusual or severe symptoms related to injections early and get them treated
These are complex and valid questions
The Glucagon-Like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: A randomized controlled trial
Great lean protein sources include chicken, fish, eggs, tofu, or low-fat dairy
Even without substantial weight loss, blood sugar typically improves
Whether your insurance covers a GLP-1 and how much it covers depends on three factors: the drug's indication, your specific plan, and whether you meet clinical criteria